Physician profile
Vincent Tam
NPI 1356439491
$1,154.73
in general payments reported to CMS, 2019-2025
7 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.46 · 2021: $33.36 · 2022: $40.08 · 2024: $16.66 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $617 · Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $617.46 |
| Food and Beverage | $403.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $847.29 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $175.22 | 2025 | Aurora Ev-Icd Mri Surescan |
| Edwards Lifesciences Corporation | $53.58 | 2021-2022 | |
| Melinta Therapeutics, LLC | $42.12 | 2019 | |
| Artivion, INC. | $19.86 | 2022 | |
| Lemaitre Vascular, INC. | $16.66 | 2024 | Restoreflow |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.